We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Debiopharm Group to Support Ascepion in the Development of Debio 1144

News   Apr 18, 2013

 
Debiopharm Group to Support Ascepion in the Development of Debio 1144
 
 
 

RELATED ARTICLES

The First Precision Medicine Clinical Trial for Dogs With Lung Cancer

News

A "ground-breaking" new study led by the Translational Genomics Research Institute (TGen) suggests that the HER2 gene that

same gene is the cause of lung cancer in many dogs. Their findings, published in the journal Clinical Cancer Research, offer novel avenues for precision medicine in dogs.

READ MORE

Kissing Loops Essential for Tumor Suppression

News

A team of researchers in the Marcia group at EMBL Grenoble have discovered that the tumour suppressor MEG3 adopts a complex three-dimensional structure to fulfil its function. Furthermore, they were able to fine-tune its activity by targeted manipulation of this architecture.

READ MORE

$1.7 Million Grant to Study Potential Skin Cancer Treatment

News

Ohio University scientists have been awarded a five-year $1.7 million grant to advance research on a potential prevention and treatment for non-melanoma skin cancers.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE